Answers are grounded in this paper and cite their sources.
Dermal substitutes have provided a template for the regeneration and reconstruction of the dermis. However, the healed skin tissue often exhibits abnormal morphology and functionality, including scarring and inflammation. In this study, a composite bioink composed of methacrylated gelatin (GelMA) and chitosan oligosaccharide (COS) was proposed for printing a dermal scaffold using digital light processing (DLP) technology. The GelMA/COS bioink exhibited suitable porosity, swelling, degradation rate, and mechanical properties. The inclusion of COS demonstrated antibacterial effects against both Grampositive and Gram-negative bacteria, while simultaneously fostering the proliferation of human dermal fibroblasts (HDFs). Additionally, the application of COS could effectively reduce the expression levels of fibrosis-related genes, such as collagen I, collagen III, and fibronectin I. The three-dimensionally printed cell-laden dermal scaffold exhibited excellent shape fidelity and high cellular viability, facilitating the extension of HDFs along the scaffold and the simultaneous secretion of extracellular matrix proteins. Furthermore, the HDF-laden dermal scaffold transplanted into full-thickness skin defect sites in nude mice was shown to accelerate wound closure, reduce inflammation, and improve wound healing. Overall, the DLP-printed dermal scaffold provides an appealing approach for effectively treating full-thickness skin defects in clinical settings.
No takes yet. Share an insight, caveat, or question.
Han et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: